ALCJ.PA
Crossject SA
Price:  
1.00 
EUR
Volume:  
352,640.00
France | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALCJ.PA WACC - Weighted Average Cost of Capital

The WACC of Crossject SA (ALCJ.PA) is 5.6%.

The Cost of Equity of Crossject SA (ALCJ.PA) is 6.15%.
The Cost of Debt of Crossject SA (ALCJ.PA) is 5.00%.

Range Selected
Cost of equity 5.10% - 7.20% 6.15%
Tax rate 15.20% - 16.10% 15.65%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.8% - 6.3% 5.6%
WACC

ALCJ.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.27 0.4
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.10% 7.20%
Tax rate 15.20% 16.10%
Debt/Equity ratio 0.41 0.41
Cost of debt 5.00% 5.00%
After-tax WACC 4.8% 6.3%
Selected WACC 5.6%

ALCJ.PA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ALCJ.PA:

cost_of_equity (6.15%) = risk_free_rate (3.25%) + equity_risk_premium (6.30%) * adjusted_beta (0.27) + risk_adjustments (0.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.